Resverlogix Corp T.RVX

Alternate Symbol(s): RVXCF

Healthcare Biotechnology

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

TSX:RVX - Post by User

Resverlogix Corp > Faith Shaken

<< Previous

Bullboard Posts

Next >>

Comment by Jesus4Prezon Dec 04, 2020 4:36pm

218 Views

Post# 32039697

RE:RE:Faith Shaken

When a woman is pregnant she feels like the pregnancy will never end. She is increasingly uncomfortable as the delivery nears. It is similar with shareholders, but to be clear, Moms deserve way more respect than shareholders, and the gift of life is much greater than financial reward! Waiting does not signal the event will not occur.

<< Previous

Bullboard Posts

Next >>

Bombardier Defense expands in Australia